reglab/statecodes huggingface dataset:
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1720.1 - Graduates of Foreign Pharmacy Schools

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Graduates of foreign pharmacy schools who have been certified
				  by the Foreign Pharmacy Graduate Equivalency Committee shall be deemed by the
				  board to have satisfied the requirements of paragraphs (3) and (4) of Business
				  and Professions Code Section
				  4200(a).
				  Candidates who have been certified by the Foreign Pharmacy Graduate Equivalency
				  Committee before January 1, 1998, must also provide the board with a score on
				  the Test of Spoken English of least 50. For candidates who took the Test of
				  Spoken English before June 30, 1995, a score of at least 220 must be
				  achieved.
1. New section
				  filed 10-31-74; effective thirtieth day thereafter (Register 74, No.
				  44).
2. Repealer filed 1-12-77; effective thirtieth day thereafter
				  (Register 77, No. 3).
3. New section filed 6-18-90; operative
				  7-17-90 (Register 90, No. 35).
4. Editorial correction of Reference
				  (Register 91, No. 24).
5. Amendment filed 3-25-96; operative 4-24-96
				  (Register 96, No. 13).
6. Change without regulatory effect amending
				  section and NOTE filed 9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
7. Amendment filed 2-11-2003;
				  operative 3-13-2003 (Register 2003, No. 7).
8. Repealer and new
				  section and amendment of NOTE filed 9-7-2005; operative 10-7-2005 (Register
				  2005, No. 36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 851
					 and
					 4200,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1721 - Dishonest Conduct During Examination

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
An applicant for examination as a pharmacist who engages in
				  dishonest conduct during the examination shall not have that examination
				  graded, shall not be approved to take the examination for three years from the
				  date of the incident, and shall surrender his or her intern license until
				  eligible to take the examination. The applicant may not be issued a pharmacy
				  technician license until the applicant is again eligible to take the
				  examination.
1. Amendment
				  filed 5-18-78; effective thirtieth day thereafter (Register 78, No.
				  20).
2. Amendment filed 11-16-82; effective thirtieth day thereafter
				  (Register 82, No. 47).
3. Change without regulatory effect amending
				  NOTE filed 9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
4. Amendment filed 9-22-2004;
				  operative 10-22-2004 (Register 2004, No. 39).
5. Amendment of
				  section and NOTE filed 8-18-2010; operative 9-17-2010 (Register 2010, No.
				  34).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 123,
					 496
					 and
					 4200,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1722 - Time and Place of Holding Examinations. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Repealer
				  filed 11-16-82; effective thirtieth day thereafter (Register 82, No.
				  47).
Note: Authority cited: Sections
					 4008
					 and
					 4008.1,
					 Business and Professions Code. Reference: Section
					 4085,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1723 - Examination. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Amendment
				  filed 5-9-52; effective thirtieth day thereafter (Register 28, No.
				  4).
2. Amendment filed 6-24-71; effective thirtieth day thereafter
				  (Register 71, No. 26).
3. Repealer filed 11-16-82; effective
				  thirtieth day thereafter (Register 82, No. 47).
Note: Authority cited: Sections
					 4008
					 and
					 4008.1,
					 Business and Professions Code. Reference: Section
					 4085,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1723.1 - Confidentiality of Examination Questions

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Examination questions are confidential. Any applicant for any
				  license issued by the board who removes all or part of any qualifying
				  examination from the examination room or area, or who conveys or exposes all or
				  part of any qualifying examination to any other person may be disqualified as a
				  candidate for a license. The applicant shall not be approved to take the
				  examination for three years from the date of the incident and shall surrender
				  his or her intern license until again eligible to take the examination. The
				  applicant may not be issued a pharmacy technician license until the applicant
				  is again eligible to take the examination.
1. New section
				  filed 10-31-74; effective thirtieth day thereafter (Register 74, No.
				  44).
2. Change without regulatory effect amending NOTE filed
				  9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
3. Amendment of section and
				  NOTE filed 9-22-2004; operative 10-22-2004 (Register 2004, No.
				  39).
4. Amendment filed 8-18-2010; operative 9-17-2010 (Register
				  2010, No. 34).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 123
					 and
					 496,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1724 - Passing Grade in Pharmacist Examination

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
In order to pass the examination, an applicant shall be
				  required to obtain a passing score as determined by a criterion-referenced
				  method of establishing the passing point on each part of the examination. The
				  board may scale the passing score to 75 for the purpose of releasing scores to
				  examinees.
1. Amendment
				  filed 5-18-86 as an emergency; effective upon filing (Register 56, No.
				  9).
2. Amendment filed 6-7-56 as an emergency; effective upon filing
				  (Register 56, No. 11).
3. Amendment filed 11-16-82; effective
				  thirtieth day thereafter (Register 82, No. 47).
4. Amendment filed
				  5-16-83; effective thirtieth day thereafter (Register 83, No.
				  21).
5. Amendment of subsections (a) and (b) filed 5-18-89;
				  operative 5-18-89 pursuant to Government Code section
				  11346.2(d)
				  (Register 89, No. 21).
6. Repealer and new text filed 12-5-94;
				  operative 2-1-95 (Register 94, No. 49).
7. Change without regulatory
				  effect amending NOTE filed 9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
8. Amendment of section heading
				  and repealer and new section filed 9-22-2004; operative 10-22-2004 (Register
				  2004, No. 39).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Section
					 4200,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1725 - Acceptable Pharmacy Coursework for Examination Candidates with Four Failed Attempts

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a)
				Coursework that meets the requirements of section
				4200.1
				of the Business and Professions Code is any pharmacy coursework offered by a
				recognized school of pharmacy.
(b)
				A final examination must be a part of the course of study.
(c) When a candidate applies for
				reexamination after four failed attempts, he or she shall furnish evidence of
				successful completion of at least 16 semester units or the equivalent of
				pharmacy coursework. Evidence of successful completion must be posted on a
				transcript from the pharmacy school sent directly to the board.
1. New section
				  filed 10-5-98; operative 11-4-98 (Register 98, No. 41). For prior history, see
				  Register 83, No. 12.
2. Amendment of subsection (a) filed 9-7-2005;
				  operative 10-7-2005 (Register 2005, No. 36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Section
					 4200.1,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1726 - Supervision of Intern Pharmacists

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) The pharmacist supervising an intern
				pharmacist shall be responsible for all professional activities performed by
				the intern under his or her supervision.
(b) The pharmacist supervising an intern
				pharmacist shall provide the experience necessary for the intern pharmacist to
				become proficient in the practice of pharmacy.
1. New section
				  filed 5-14-69; effective thirtieth day thereafter (Register 69, No.
				  20).
2. Amendment of subsections (e) and (g) filed 5-18-78;
				  effective thirtieth day thereafter (Register 78, No. 20).
3.
				  Amendment filed 8-3-79; effective thirtieth day thereafter (Register 79, No.
				  31).
4. Amendment and new subsections (b) and (c) filed 11-16-82;
				  effective thirtieth day thereafter (Register 82, No. 47).
5. Change
				  without regulatory effect amending NOTE filed 9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
6. Repealer and new section
				  heading and amendment of section filed 9-7-2005; operative 10-7-2005 (Register
				  2005, No. 36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 4030,
					 4114
					 and
					 4200,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1727 - Intern Pharmacist. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. New section
				  filed 5-14-69; effective thirtieth day thereafter (Register 69, No.
				  20).
2. Amendment filed 8-3-79; effective thirtieth day thereafter
				  (Register 79, No. 31).
3. Amendment filed 11-16-82; effective
				  thirtieth day thereafter (Register 82, No. 47).
4. New subsection
				  (e) filed 4-20-83; effective thirtieth day thereafter (Register 83, No.
				  17).
5. Change without regulatory effect amending subsections (b)(3)
				  and (e) and NOTE filed 9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
6. Repealer filed 9-7-2005;
				  operative 10-7-2005 (Register 2005, No. 36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 4030,
					 4114
					 and
					 4200,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1727.1 - Intern Pharmacist Address

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
The board shall not make an intern pharmacist's address
				  publicly available on the "Internet," as defined by Business and Professions
				  Code section
				  17538.
1. New section
				  filed 8-31-2006; operative 9-30-2006 (Register 2006, No.
				  35).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 4005,
					 4030,
					 4100
					 and
					 4208,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1727.2 - Requirements for Pharmacist Intern

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Every applicant for a pharmacist intern license shall submit
				  as part of the application process, a sealed, original Self Query Report from
				  the National Practitioner Data Bank-Healthcare Integrity and Protection Data
				  Bank (NPDB-HIPDB), dated no earlier than 60 days before the date an application
				  is submitted to the board.
1. New section
				  filed 6-18-2012; operative 7-18-2012 (Register 2012, No.
				  25).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 4207
					 and
					 4208,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1728 - Requirements for Examination

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a)
				Prior to receiving authorization from the board to take the pharmacist
				licensure examinations required by section
				4200
				of the Business and Professions Code, applicants shall submit to the board the
				following:
(1) Proof of 1500 hours of
				pharmacy practice experience that meets the following requirements:
(A) A minimum of 900 hours of pharmacy
				practice experience obtained in a pharmacy.
(B) A maximum of 600 hours of pharmacy
				practice experience may be granted at the discretion of the board for other
				experience substantially related to the practice of pharmacy.
(C) Experience in both community pharmacy and
				institutional pharmacy practice settings.
(D) Pharmacy practice experience that
				satisfies the requirements for both introductory and advanced pharmacy practice
				experiences established by the Accreditation Council for Pharmacy
				Education.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3 - Pharmacist Candidates › Section 1729 - Preceptor Activities. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. New section
				  filed 3-28-46; effective thirtieth day thereafter (Register 56, No.
				  6).
2. Amendment filed 7-24-58; effective thirtieth day thereafter
				  (Register 58, No. 13).
3. Amendment filed 5-14-69; effective
				  thirtieth day thereafter (Register 69, No. 20).
4. Amendment filed
				  7-25-75; effective thirtieth day thereafter (Register 75, No.
				  30).
5. Amendment filed 8-3-79; effective thirtieth day thereafter
				  (Register 79, No. 31).
6. Repealer filed 11-16-82; effective
				  thirtieth day thereafter (Register 82, No. 47).
Note: Authority cited: Sections
					 4008
					 and
					 4008.1,
					 Business and Professions Code. Reference: Sections
					 4038.1,
					 4085,
					 4087
					 and
					 4097,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3.5 - Advanced Practice Pharmacist › Section 1730 - Acceptable Certification Programs

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
The board recognizes the pharmacy patient care certification
				  programs that are accredited by the National Commission for Certifying Agencies
				  for purposes of satisfying the requirements in Business and Professions Code
				  section
				  4210,
				  subdivision (a)(2)(A).
1. New article
				  3.5 (sections
				  1730-1731) and section filed
				  12-13-2016; operative 12-13-2016 pursuant to Government Code section
				  11343.4(b)(3)
				  (Register 2016, No. 51). For prior history of article 3, section
				  1730, see Register 2002, No.
				  37.
Note: Authority cited: Sections
					 4005
					 and
					 4210,
					 Business and Professions Code. Reference: Section
					 4210,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3.5 - Advanced Practice Pharmacist › Section 1730.1 - Application Requirements for Advanced Practice Pharmacist Licensure

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) For purposes of
				Business and Professions Code section
				4210,
				an applicant for advanced practice pharmacist licensure must satisfy two of the
				following subsections.
(1) Demonstrate
				possession of a current certification as specified in Business and Professions
				Code section
				4210,
				subdivision (a)(2)(A)(i), by providing either:
(A) A copy of the certification award that
				includes the name of the applicant pharmacist, the area of specialty and date
				of completion, or
(B) A letter from
				the certification program confirming the award of the certification that
				includes the name of the applicant pharmacist, the area of specialty and the
				date of completion.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3.5 - Advanced Practice Pharmacist › Section 1730.2 - Certification Programs

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) For
				purposes of Business and Professions Code section
				4210,
				subdivision (a)(2)(A), general clinical pharmacy practice is among the relevant
				areas of practice for which certification may be earned.
(b) For a pharmacist seeking to demonstrate
				certification in general clinical pharmacy as a criterion for advanced practice
				pharmacist licensure by the board, the certification may be earned from an
				organization recognized as a continuing education provider by the Accreditation
				Council for Pharmacy Education or accredited by the National Commission for
				Certifying Agencies as a certification provider, so long as:
(1) The certification program includes
				specified learning objectives in at least five sequentially-ordered education
				modules, covering the following topics: performing patient assessments;
				ordering and interpreting drug therapy-related tests; referring patients to
				other health care providers; participating in the evaluation and management of
				diseases and health conditions in collaboration with other health care
				providers; and initiating, adjusting, modifying or discontinuing drug
				therapy;
(2) The certification
				program requires assessment after completion of each of the education modules
				in an examination format or by other assessment methodology that confirms the
				participant's understanding, knowledge, and application of the specified
				learning objectives for the module, where any failure to successfully complete
				the assessment in any module prevents advancement to the next module;
(3) The certification program requires that
				instruction and assessments in each of the modules are developed and provided
				by either:
(A) An advanced practice pharmacist
				licensed by the board or
(B) An
				expert with experience in the respective area(s) of focus specified in
				subparagraph (1), where "expert" means a person who qualifies to teach at a
				school of pharmacy recognized by the board.
(4) The certification program requires that,
				upon successful completion of all modules and their respective assessments,
				each participant shall earn a passing score on a final overall assessment
				before being awarded certification. The assessment shall be either a final
				written examination or an objective structured clinical examination developed
				and administered in collaboration with an accredited school of pharmacy
				recognized by the board; and
(5)
				The certification program require(s) a minimum of ten hours of continuing
				education on the topics identified in (b)(1) every two years to maintain
				certification.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 3.5 - Advanced Practice Pharmacist › Section 1731 - Experimental Programs. [Renumbered]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. New section
				  filed 4-24-70; effective thirtieth day thereafter (Register 70, No. 17). For
				  prior history see Register 66, No. 23.
2. Editorial correction of
				  subsection (a) (Register 95, No. 16).
3. Change without regulatory
				  effect renumbering former section
				  1731 to new section
				  1706.5 filed 9-11-2002 pursuant to
				  section 100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
4. Relocation of section
				  1731 from former article 3 to new
				  article 3.5 filed 12-13-2016; operative 12-13-2016 pursuant to Government Code
				  section
				  11343.4(b)(3)
				  (Register 2016, No. 51).
Note: Authority cited: Sections
					 4008,
					 4008.1,
					 4008.2,
					 Business and Professions Code. Reference: Sections
					 4008,
					 4008.1,
					 4008.2,
					 4084.5,
					 4084.6
					 and
					 4416,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732 - Definitions

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
As used in this article:
(a) "Accreditation agency" means an
				organization which evaluates and accredits providers of continuing education
				for pharmacists.
(b) "Hour" means
				at least 50 minutes of contact time.
(c) "Provider" means a person who has been
				accredited by an approved accreditation agency or accredited by the board to
				provide a specific continuing education course.
1. New Article
				  4.5 (Sections
				  1732-1732.4) filed 8-3-73;
				  designated effective 11-1-73 (Register 73, No. 31). For history of former
				  section, see Register 21, No. 7.
2. New subsections (d) and (e)
				  filed 1-12-77; effective thirtieth day thereafter (Register 77, No.
				  3).
3. Amendment filed 4-17-85; effective thirtieth day thereafter
				  (Register 85, No. 16).
4. Amendment filed 12-9-88; operative 1-1-89
				  (Register 88, No. 52).
5. Repealer of subsection (a), subsection
				  relettering and amendment of NOTE filed 11-18-99; operative 12-18-99 (Register
				  99, No. 47).
6. Change without regulatory effect renumbering former
				  article 4.5 to article 4 filed 9-11-2002 pursuant to section
				  100, title 1, California Code of
				  Regulations (Register 2002, No. 37).
7. Amendment filed 9-7-2005;
				  operative 10-7-2005 (Register 2005, No. 36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Section
					 4232,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.05 - Accreditation Agencies for Continuing Education

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) The following organizations are approved
				accreditation agencies:
(1) The Accreditation
				Council for Pharmacy Education.
(2)
				The California Pharmacists Association.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.1 - Requirements for Accredited Providers

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) No person shall provide continuing
				pharmacy education without being accredited by an approved accreditation agency
				or having the course accredited by the board pursuant to section
				1732.2 of this Division.
(b) Providers shall ensure that each
				continuing education course complies with the requirements of section
				1732.3 of this Division.
(c) Providers shall furnish statements of
				credit to all participants that complete a continuing education course. The
				statement of credit shall contain the name of the enrollee, name and number of
				the provider, title of the course, number of completed hours, date of
				completion, expiration date of the coursework, course number, if applicable and
				the name of the accrediting agency.
(d) Each provider shall notify the
				accreditation agency at least 15 days in advance of the first time each new
				continuing education course is offered or presented.
(e) Providers shall maintain records of
				completion of their continuing education courses for four years.
(f) Providers shall include the following
				information in promotional materials regarding continuing education courses:
(1) Provider's name.
(2) The number of hours awarded for
				completion of the course.
(3) The
				date when the course's accreditation expires.
(4) The provider number assigned by the
				accreditation agency.
(5) The name
				of the provider's accrediting agency.
(6) The learning objectives of the
				program.
(7) The nature of the
				targeted audiences that may best benefit from participation in the
				program.
(8) The speakers and their
				credentials.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.3 - Requirements for Continuing Education Courses

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Unless denied by the accreditation agency
				upon audit, all coursework offered by providers may be used to satisfy the
				continuing education required by section
				1732.5 of this Division.
(b) On a random basis or in response to a
				requests by the board, the accreditation agency shall review selected
				coursework. The material shall be forwarded to a reviewer to judge the quality
				of the program on the basis of factors established by the accreditation agency
				in addition to the requirements of this section.
(c) A recognized provider's coursework shall
				be valid for up to three years following the initial presentation provided that
				the information is still current.
(d) Continuing education courses shall comply
				with the following:
(1) Courses shall have
				specific, measurable learning objectives which serve as a basis for an
				evaluation of the program's effectiveness.
(2) Speakers, or those developing the content
				of the course, shall be competent in the subject matter and shall be qualified
				by education, training and/or experience.
(3) Courses shall have a syllabus which
				provides a general outline of the course. The syllabus shall contain at a
				minimum, the learning objectives for each course and a summary containing the
				main points for each topic.
(4)
				Courses shall include a mechanism that allows all participants to assess their
				achievement in accordance with the program's learning
				objectives.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.4 - Provider Audit Requirements

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Upon written request from the accreditation agency, relating
				  to an audit of continuing education course, each provider shall submit such
				  materials as are required by the accreditation agency.
1. New
				  subsection (c) filed 1-12-77; effective thirtieth day thereafter (Register 77,
				  No. 3).
2. Amendment filed 4-17-85; effective thirtieth day
				  thereafter (Register 85, No. 16).
3. Amendment filed 12-9-88;
				  operative 1-8-89 (Register 88, No. 52).
4. Editorial correction of
				  printing error restoring previously omitted section (Register 91, No.
				  30).
5. Repealer of subsection (a) designator and amendment of NOTE
				  filed 11-18-99; operative 12-18-99 (Register 99, No. 47).
6.
				  Amendment filed 9-7-2005; operative 10-7-2005 (Register 2005, No.
				  36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Section
					 4232,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.5 - Renewal Requirements for Pharmacists

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Except as provided in Section
				4234
				of the Business and Professions Code and Section
				1732.6 of this Division, each
				applicant for renewal of a pharmacist license shall submit proof satisfactory
				to the board, that the applicant has completed 30 hours of continuing education
				in the prior 24 months.
(b) At
				least two (2) of the thirty (30) hours required for pharmacist license renewal
				shall be completed by participation in a Board provided CE course in Law and
				Ethics. Pharmacists renewing their licenses which expire on or after July 1,
				2019, shall be subiect to the requirements of this subdivision.
(c) All pharmacists shall retain their
				certificates of completion for four (4) years following completion of a
				continuing education course.
1. New section
				  filed 1-12-77; effective thirtieth day thereafter (Register 77, No.
				  3).
2. Repealer of former Section
				  1732.5 and renumbering and
				  amendment of former Section
				  1732.2 to new Section
				  1732.5 filed 4-17-85; effective
				  thirtieth day thereafter (Register 85, No. 16).
3. Amendment of
				  subsection (a) filed 12-9-88; operative 1-8-89 (Register 88, No.
				  52).
4. Amendment of subsection (a) and amendment of NOTE filed
				  11-18-99; operative 12-18-99 (Register 99, No. 47).
5. Amendment
				  filed 9-7-2005; operative 10-7-2005 (Register 2005, No. 36).
6.
				  Amendment of section heading, new subsection (b), subsection relettering and
				  amendment of newly designated subsection (c) filed 3-20-2017; operative
				  7-1-2017 (Register 2017, No. 12).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Sections
					 4231
					 and
					 4232,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.6 - Exemptions

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
Pharmacists may seek exemption from the continuing education
				  requirements for renewal on the grounds of emergency or hardship by applying to
				  the board in writing setting forth the reasons why such exemption should be
				  granted. Exemptions may be granted for such reasons as illness or full-time
				  enrollment in a health professional school.
1. New section
				  filed 1-12-77; effective thirtieth day thereafter (Register 77, No.
				  3).
2. Repealer of former Section
				  1732.6 and renumbering and
				  amendment of former Section
				  1732.3 to new Section
				  1732.6 filed 4-17-85; effective
				  thirtieth day thereafter (Register 85, No. 16).
3. Amendment of NOTE
				  filed 11-18-99; operative 12-18-99 (Register 99, No. 47).
4.
				  Amendment filed 9-7-2005; operative 10-7-2005 (Register 2005, No.
				  36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Section
					 4234,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.7 - Complaint Mechanism

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
A provider may request reconsideration of any adverse action
				  taken against the provider or its coursework by an accreditation agency.
				  Following such reconsideration, the provider may request review of the
				  accreditation agency's decision by the board.
1. New section
				  filed 1-12-77; effective thirtieth day thereafter (Register 77, No.
				  3).
2. Amendment filed 4-17-85; effective thirtieth day thereafter
				  (Register 85, No. 16).
3. Amendment filed 12-9-88; operative 1-8-89
				  (Register 88, No. 52).
4. Amendment of NOTE filed 11-18-99;
				  operative 12-18-99 (Register 99, No. 47).
5. Amendment filed
				  9-7-2005; operative 10-7-2005 (Register 2005, No.
				  36).
Note: Authority cited: Section
					 4005,
					 Business and Professions Code. Reference: Section
					 4232,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.8 - Accreditation Procedure. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. New section
				  filed 1-12-77; effective thirtieth day thereafter (Register 77, No.
				  3).
2. Repealer filed 4-17-85; effective thirtieth day thereafter
				  (Register 85, No. 16).
Note: Authority cited: Sections
					 4008
					 and
					 4098.3,
					 Business and Professions Code. Reference: Section
					 4098.3,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1732.9 - Accreditation Procedure Waiver. [Repealed]

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. New section
				  filed 1-12-77; effective thirtieth day thereafter (Register 77, No.
				  3).
2. Repealer filed 4-17-85; effective thirtieth day thereafter
				  (Register 85, No. 16).
Note: Authority cited: Sections
					 4008
					 and
					 4098.3,
					 Business and Professions Code. Reference: Section
					 4098.3,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4 - Continuing Education › Section 1733

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
1. Repealer of
				  Sections 1733 through
				  1739, and new Sections
				  1733 through
				  1739 filed 11-3-55; designated
				  effective 2-1-56 (Register 55, No. 16). For prior history, see Register 28, No.
				  4.
2. Amendment filed 7-24-75; effective thirtieth day thereafter
				  (Register 75, No. 30).
3. Repealer of Article 5 (Sections
				  1733-1738) filed 1-28-81;
				  effective thirtieth day thereafter (Register 81, No.
				  5).
Note: Authority cited: Section
					 4312,
					 Business and Professions Code. Reference: Sections
					 4300-
					 4325,
					 Business and Professions Code.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4.5 - Compounding › Section 1735 - Compounding in Licensed Pharmacies

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) "Compounding" means any of the following
				activities occurring in a licensed pharmacy, by or under the supervision of a
				licensed pharmacist, pursuant to a prescription:
(1) Altering the dosage form or delivery
				system of a drug
(2) Altering the
				strength of a drug
(3) Combining
				components or active ingredients
(4) Preparing a compounded drug preparation
				from chemicals or bulk drug substances
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4.5 - Compounding › Section 1735.1 - Compounding Definitions

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a)
				"Ante-area" means an area with ISO Class 8 or better air quality where
				personnel hand hygiene and garbing procedures, staging of components, and other
				high-particulate-generating activities are performed, that is adjacent to the
				area designated for sterile compounding. It is a transition area that begins
				the systematic reduction of particles, prevents large fluctuations in air
				temperature and pressures in the cleanroom, and maintains air flows from clean
				to dirty areas. ISO Class 7 or better air quality is required for ante-areas
				providing air to a negative pressure room.
(b) "Beyond use date" means the date, or date
				and time, after which administration of a compounded drug preparation shall not
				begin, the preparation shall not be dispensed, and the preparation shall not be
				stored (other than for quarantine purposes).
(c) "Biological Safety Cabinet (BSC)" means a
				ventilated cabinet for compounding sterile drug preparations, having an open
				front with inward airflow for personnel protection, downward HEPA-filtered
				laminar airflow for product protection, and HEPA-filtered exhausted air for
				environmental protection. Where hazardous drugs are prepared, the exhaust air
				from the biological safety cabinet shall be appropriately removed by properly
				designed external building exhaust. This external exhaust should be dedicated
				to one BSC or CACI.
(d) "Bulk drug
				substance" means any substance that, when used in the preparation of a
				compounded drug preparation, processing, or packaging of a drug, is an active
				ingredient or a finished dosage form of the drug, but the term does not include
				any intermediate used in the synthesis of such substances.
(e) "Cleanroom or clean area or buffer area"
				means a room or area with HEPA-filtered air that provides ISO Class 7 or better
				air quality where the primary engineering control (PEC) is physically located.
(1) For nonhazardous compounding a positive
				pressure differential of 0.02- to 0.05-inch water column relative to all
				adjacent spaces is required.
(2)
				For hazardous compounding at least 30 air changes per hour of HEPA-filtered
				supply air and a negative pressure of between 0.01 to 0.03 inches of water
				column relative to all adjacent spaces is required.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4.5 - Compounding › Section 1735.2 - Compounding Limitations and Requirements; Self-Assessment

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Except as specified in (b) and (c), no
				drug preparation shall be compounded prior to receipt by a pharmacy of a valid
				prescription for an individual patient where the prescriber has approved use of
				a compounded drug preparation either orally or in writing. Where approval is
				given orally, that approval shall be noted on the prescription prior to
				compounding.
(b) A pharmacy may
				prepare and store a limited quantity of a compounded drug preparation in
				advance of receipt of a patient-specific prescription where and solely in such
				quantity as is necessary to ensure continuity of care for an identified
				population of patients of the pharmacy based on a documented history of
				prescriptions for that patient population.
(c) A "reasonable quantity" that may be
				furnished to a prescriber for office use by the prescriber as authorized by
				Business and Professions Code section
				4052,
				subdivision (a)(1), means that amount of compounded drug preparation that:
(1) Is ordered by the prescriber or the
				prescriber's agent using a purchase order or other documentation received by
				the pharmacy prior to furnishing that lists the number of patients seen or to
				be seen in the prescriber's office for whom the drug is needed or anticipated,
				and the quantity for each patient that is sufficient for office administration;
				and
(2) Is delivered to the
				prescriber's office and signed for by the prescriber or the prescriber's agent;
				and
(3) Is sufficient for
				administration or application to patients solely in the prescriber's office, or
				for furnishing of not more than a 120-hour supply for veterinary medical
				practices, solely to the prescriber's own veterinary patients seen as part of
				regular treatment in the prescriber's office, as fairly estimated by the
				prescriber and documented on the purchase order or other documentation
				submitted to the pharmacy prior to furnishing; and
(4) That the pharmacist has a credible basis
				for concluding it is a reasonable quantity for office use considering the
				intended use of the compounded medication and the nature of the prescriber's
				practice; and
(5) With regard to
				any individual prescriber to whom the pharmacy furnishes, and with regard to
				all prescribers to whom the pharmacy furnishes, is an amount which the pharmacy
				is capable of compounding in compliance with pharmaceutical standards for
				integrity, potency, quality and strength of the compounded drug preparation;
				and
(6) Does not exceed an amount
				the pharmacy can reasonably and safely compound.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4.5 - Compounding › Section 1735.3 - Recordkeeping for Compounded Drug Preparations

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) For each compounded drug preparation,
				pharmacy records shall include:
(1) The
				master formula document.
(2) A
				compounding log consisting of a single document containing all of the
				following:
(A) Name and Strength of the
				compounded drug preparation.
(B)
				The date the drug preparation was compounded.
(C) The identity of any pharmacy personnel
				engaged in compounding the drug preparation.
(D) The identity of the pharmacist reviewing
				the final drug preparation.
(E) The
				quantity of each ingredient used in compounding the drug preparation.
(F) The manufacturer, expiration date and lot
				number of each component. If the manufacturer name is demonstrably unavailable,
				the name of the supplier may be substituted. If the manufacturer does not
				supply an expiration date for any component, the records shall include the date
				of receipt of the component in the pharmacy, and the limitations of section
				1735.2, subdivision
				(
l
) shall apply.
(i) Exempt
				from the requirements in this paragraph (1735.3(a)(2)(F)) are sterile
				preparations compounded in a single lot for administration within seventy-two
				(72) hours to a patient in a health care facility licensed under section
				1250
				of the Health and Safety Code and stored in accordance with standards for
				"Redispensed CSPs" found in Chapter 797 of the United States Pharmacopeia --
				National Formulary (USP37-NF32) Through 2nd Supplement (37th Revision,
				Effective December 1, 2014), hereby incorporated by
				reference.
(G) A
				pharmacy-assigned unique reference or lot number for the compounded drug
				preparation.
(H) The beyond use
				date or beyond use date and time of the final compounded drug preparation,
				expressed in the compounding document in a standard date and time
				format.
(I) The final quantity or
				amount of drug preparation compounded for dispensing.
(J) Documentation of quality reviews and
				required post-compounding process and procedures.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4.5 - Compounding › Section 1735.4 - Labeling of Compounded Drug Preparations

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Each compounded drug preparation shall be
				affixed with a container label prior to dispensing that contains at least:
(1) Name of the compounding pharmacy and
				dispensing pharmacy (if different);
(2) Name (brand or generic) and strength,
				volume, or weight of each active ingredient. For admixed IV solutions, the
				intravenous solution utilized shall be included;
(3) Instructions for storage, handling, and
				administration. For admixed IV solutions, the rate of infusion shall be
				included;
(4) The beyond use date
				for the drug preparation;
(5) The
				date compounded; and
(6) The lot
				number or pharmacy reference number.
California Code of Regulations › Title 16 - Professional and Vocational Regulations › Division 17 - California State Board of Pharmacy › Article 4.5 - Compounding › Section 1735.6 - Compounding Facilities and Equipment

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a) Any pharmacy engaged in compounding shall
				maintain written documentation regarding the facilities and equipment necessary
				for safe and accurate compounding of compounded drug preparations. This shall
				include records of maintenance and cleaning of the facilities and equipment.
				Where applicable, this shall also include records of certification(s) of
				facilities or equipment.
(b) Any
				equipment used to compound drug preparations shall be stored, used, maintained,
				and cleaned in accordance with manufacturers' specifications.
(c) Any equipment that weighs, measures, or
				transfers ingredients used to compound drug preparations for which calibration
				or adjustment is appropriate shall be calibrated prior to use, on a schedule
				and by a method determined by the manufacturer's specifications, to ensure
				accuracy. Documentation of each such calibration shall be recorded in a form
				which is not alterable and these records of calibration shall be maintained and
				retained in the pharmacy.
(d) Any
				pharmacy engaged in any hazardous drug compounding shall maintain written
				documentation regarding appropriate cleaning of facilities and equipment to
				prevent cross-contamination with non-hazardous drugs.
(e) Hazardous drug compounding shall be
				completed in an externally exhausted physically separate room with the
				following requirements:
(1) Minimum of 30 air
				changes per hour except that 12 air changes per hour are acceptable for
				segregated compounding areas with a BSC or CACI when products are assigned a
				BUD of 12 hours or less or when non sterile products are compounded;
				and
(2) Maintained at a negative
				pressure of 0.01 to 0.03 inches of water column relative to all adjacent spaces
				(rooms, above ceiling, and corridors); and
(3)
(A) For
				sterile compounding, each BSC or CACI shall be externally exhausted.
(B) For nonsterile compounding, a BSC, a
				CACI, or other containment ventilated enclosure shall be used and shall either
				use a redundant-HEPA filter in series or be externally exhausted. For purposes
				of this paragraph, a containment ventilated enclosure means a full or partial
				enclosure that uses ventilation principles to capture, contain, and remove
				airborne contaminants through high-efficiency particulate air (HEPA) filtration
				and to prevent their release into the work environment.
(4) All surfaces within the room shall be
				smooth, seamless, impervious, and non-shedding.